ARSUF (Fagron) Institutional Ownership : 37.46% (As of Dec. 14, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Fagron Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Fagron's institutional ownership is 37.46%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Fagron's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Fagron's Float Percentage Of Total Shares Outstanding is 0.00%.

Fagron Institutional Ownership Historical Data

The historical data trend for Fagron's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fagron Institutional Ownership Chart

Fagron Historical Data

The historical data trend for Fagron can be seen below:

	2024-02-29	2024-03-31	2024-04-30	2024-05-31	2024-06-30	2024-07-31	2024-08-31	2024-09-30	2024-10-31	2024-11-30
Institutional Ownership	38.18	38.24	37.59	37.16	37.55	37.92	38.73	38.80	39.04	39.21

Fagron Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

Fagron Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Fagron SA (OTCPK:ARSUF) » Definitions » Institutional Ownership

Comparable Companies

Traded in Other Exchanges

0HNZ:UK 4A5:Germany FAGR:Belgium

Address

Fascinatio Boulevard 350, Rotterdam, ZH, NLD, 3065 WB

Website

https://www.fagron.com

Fagron SA is a pharmaceutical compounding company operating in Belgium. It acts as a supplier of pharmaceutical care to hospitals, pharmacies, clinics, and patients across the world. The company also produces pharmaceutical raw materials, equipment, and supplies that are needed to prepare medication in the pharmacy. Its segments are namely Fagron Europe, Middle East and Africa (EMEA), Fagron North America, and Fagron Latin America. The majority of its revenue comes from Fagron North America.